Astellas Pharma Inc. Recruit

ENTRY
ENTRY
JP EN

KEYWORD

Overseas

Employees

13,643

We have a total of 13,643 active employees
(Astellas group total).

Total sales revenue

1,912.3 billion yen (For the year ended March 2025)

Revenue ratio to sales

  • United States 45.3% 866.4 billion yen
  • Japan 14.0% 267.0 billion yen
  • Established Markets 25.4% 485.4 billion yen
  • International Markets 10.6% 203.5 billion yen
  • China 4.1% 78.3 billion yen
  • Others 0.6% 11.7 billion yen
(For the year ended March 2025)

R&D Expense to Revenue Ratio

17.1%

We invest 17.1% of sales revenue development costs in R&D. We aim to achieve sustainable growth by creating novel innovative drugs.(For the year ended March 2025)

R&D Expenses

327.7 billion yen

R&D expenses totaled
327.7 billion yen(For the year ended March 2025)

Prescription drugs major pipeline

18 (number of programs)

(end of FY2025; only for Astellas Pharma Inc.)

Get informed about the working environment

Average age

42.3 years old

(end of FY2025; only for Astellas Pharma Inc.)

Average length of service

15.7 years

(end of FY2025; only for Astellas Pharma Inc.)

Overtime work hours per month

6.7 hours

(end of FY2025; only for Astellas Pharma Inc.)

Number of paid leave days taken

16.6 Day

(end of FY2025; only for Astellas Pharma Inc.)

Percentage of holidays and leave taken for childcare or nursing care

Parental leave for women 95.9%
Parental leave for men 82.5%

(end of FY2025; only for Astellas Pharma Inc.)

205 people

(end of FY2025; only for Astellas Pharma Inc.)

Employees who run a sideline business

(end of FY2025; only for Astellas Pharma Inc.)